Kolexia
Chinot Olivier Oncologie radiothérapie
Chinot Olivier
Oncologie radiothérapie
Hôpital La Timone
Marseille, France
367 Activités
41 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Glioblastome Tumeurs du cerveau Gliome Lymphomes Récidive tumorale locale Tumeurs du système nerveux central Méningiome Astrocytome Oligodendrogliome

Collaborateurs

Voir plus
Figarella-Branger Dominique
Figarella-Branger Dominique
Hôpital La Timone, Marseille, France
Tabouret Emeline
Tabouret Emeline
Hôpital La Timone, Marseille, France
Barrie-Attarian Maryline
Barrie-Attarian Maryline
Hôpital La Timone, Marseille, France
Metellus Philippe
Metellus Philippe
Cabinet libéral, Marseille, France

Industries

Voir plus
Servier
3 collaboration(s)
Dernière en 2023
B3TSI
1 collaboration(s)
Dernière en 2020
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
GBM AGILE: Global Adaptive Trial Master Protocol: An International, Seamless Phase II/III Response Adaptive Randomization Platform Trial Designed To Evaluate Multiple Regimens In Newly Diagnosed and Recurrent GBM
Essai Clinique (Biohaven Pharmaceuticals, Inc.)   21 mars 2024
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysis.
Journal of neuro-oncology   07 mars 2024
MM-Predict: Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
Essai Clinique (Assistance publique - Hôpitaux de Marseille)   04 mars 2024
Repeated blood-brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trial.
Nature communications   23 février 2024
SONOBIRD: A Randomized, Open-label, Multicentric, Two-arm Pivotal Trial of SonoCloud-9 Combined With Carboplatin (CBDCA) vs Standard of Care Lomustine (CCNU) or Temozolomide (TMZ) in Patients Undergoing Planned Resection for First Recurrence Glioblastoma.
Essai Clinique (CarThera)   30 janvier 2024
LOC-R01: Randomized Phase IB/II Study of Escalating Doses of Lenalidomide and Ibrutinib in Association With R-MPV as a Targeted Induction Treatment for Patients Aged 18 to 60 (up to 65 for Phase II) With a Newly Diagnosed Primary Central Nervous System Lymphoma
Essai Clinique (Institut Curie)   10 janvier 2024
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.
Journal of the neurological sciences   18 décembre 2023
Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.
European journal of cancer (Oxford, England : 1990)   18 décembre 2023
PersoMed-I: Personalized Risk-Adapted Therapy in Post-Pubertal Patients With Newly-Diagnosed Medulloblastoma (PersoMed-I)
Essai Clinique (Organisation européenne pour la recherche et le traitement du cancer)   08 décembre 2023
A Study in Recurrent Glioblastoma (GB): A Phase 2 Study of LY2157299 Monohydrate Monotherapy or LY2157299 Monohydrate Plus Lomustine Therapy Compared to Lomustine Monotherapy in Patients With Recurrent Glioblastoma
Essai Clinique (Lilly)   05 décembre 2023